Significance of S100A2 and S100A4 expression in the progression of prostate adenocarcinoma

Korean Journal of Urology

Volumn 51, Issue 7, 2010, Pages 456-462

  Kwon, Yong Wook ^a   Chang, In Ho ^a   Kim, Kyung Do ^a   Kim, Young Sun ^a   Myung, Soon Chul ^a   Kim, Mi Kyung ^a   Kim, Tae Hyoung ^a  

^a Chung Ang University College of Medicine   (South Korea)

Author keywords

Human; Prostatic hyperplasia; Prostatic neoplasms; S100A2 protein; S100A4 protein

Indexed keywords

CALCIUM BINDING PROTEIN; CALVASCULIN; PROTEIN S 100A2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; HUMAN; HUMAN TISSUE; MALE; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION;

EID: 77954962981     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2010.51.7.456     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
2. Ministry for Health, Welfare and Family Affairs. Annual report of cancer incidence (2005) and survival (1993-2005) in Korea. Seoul: The Ministry; 2008.
3. Klein EA, Thompson IM. Update on chemoprevention of prostate cancer. Curr Opin Urol 2004;14:143-9.
4. Saleem M, Adhami VM, Zhong W, Longley BJ, Lin CY, Dickson RB, et al. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1. Cancer Epidemiol Biomarkers Prev 2006;15:217-27. (Pubitemid 43342167)
5. Ilg EC, Schäfer BW, Heizmann CW. Expression pattern of S100 calcium-binding proteins in human tumors. Int J Cancer 1996;68:325-32.
6. Heizmann CW. The multifunctional S100 protein family. Methods Mol Biol 2002;172:69-80.
7. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001;33:637-68.
8. Lee SW, Tomasetto C, Swisshelm K, Keyomarsi K, Sager R. Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. Proc Natl Acad Sci U S A 1992;89:2504-8.
9. Liu D, Rudland PS, Sibson DR, Platt-Higgins A, Barraclough R. Expression of calcium-binding protein S100A2 in breast lesions. Br J Cancer 2000;83:1473-9.
10. Maelandsmo GM, Florenes VA, Mellingsaeter T, Hovig E, Kerbel RS, Fodstad O. Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma. Int J Cancer 1997;74:464-9.
11. Nagy N, Hoyaux D, Gielen I, Schafer BW, Pochet R, Heizmann CW, et al. The Ca2+-binding S100A2 protein is differentially expressed in epithelial tissue of glandular or squamous origin. Histol Histopathol 2002;17:123-30.
12. Feng G, Xu X, Youssef EM, Lotan R. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis. Cancer Res 2001;61:7999-8004. (Pubitemid 33049393)
13. Bronckart Y, Decaestecker C, Nagy N, Harper L, Schafer BW, Salmon I, et al. Development and progression of malignancy in human colon tissues are correlated with expression of specific Ca(2+)-binding S100 proteins. Histol Histopathol 2001;16:707-12.
14. Lauriola L, Michetti F, Maggiano N, Galli J, Cadoni G, Schafer BW, et al. Prognostic significance of the Ca(2+) binding protein S100A2 in laryngeal squamous-cell carcinoma. Int J Cancer 2000;89:345-9.
15. Sherbet GV, Lakshmi MS. S100A4 (MTS1) calcium binding protein in cancer growth, invasion and metastasis. Anticancer Res 1998;18:2415-21.
16. Grigorian MS, Tulchinsky EM, Zain S, Ebralidze AK, Kramerov DA, Kriajevska MV, et al. The mts1 gene and control of tumor metastasis. Gene 1993;135:229-38.
17. Taylor S, Herrington S, Prime W, Rudland PS, Barraclough R. S100A4 (p9Ka) protein in colon carcinoma and liver metastases: association with carcinoma cells and T-lymphocytes. Br J Cancer 2002;86:409-16.
18. Garrett SC, Varney KM, Weber DJ, Bresnick AR. S100A4, a mediator of metastasis. J Biol Chem 2006;281:677-80.
19. Schafer BW, Heizmann CW. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 1996;21:134-40.
20. Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965;19:739-44.
21. Sun Y. Identification and characterization of genes responsive to apoptosis: application of DNA chip technology and mRNA differential display. Histol Histopathol 2000;15:1271-84.
22. Tan M, Heizmann CW, Guan K, Schafer BW, Sun Y. Transcriptional activation of the human S100A2 promoter by wild-type p53. FEBS Lett 1999;445:265-8.
23. Nagy N, Brenner C, Markadieu N, Chaboteaux C, Camby I, Schafer BW, et al. S100A2, a putative tumor suppressor gene, regulates in vitro squamous cell carcinoma migration. Lab Invest 2001;81:599-612. (Pubitemid 32298806)
24. Barraclough R. Calcium-binding protein S100A4 in health and disease. Biochim Biophys Acta 1998;1448:190-9. (Pubitemid 29052192)
25. Rudland PS, Platt-Higgins A, Renshaw C, West CR, Winstanley JH, Robertson L, et al. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 2000;60:1595-603.
26. Takenaga K, Nakanishi H, Wada K, Suzuki M, Matsuzaki O, Matsuura A, et al. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. Clin Cancer Res 1997;3:2309-16. (Pubitemid 28133150)